Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2R,5R,8R,11R,14R,17R,20R,23R,26R,29R,32R,35R)-35,39-diamino-32-(4-aminobutyl)-20,23-dibenzyl-5,8,11,14-tetrakis(3-guanidinopropyl)-29-isobutyl-26-isopropyl-2,17-dimethyl-4,7,10,13,16,19,22,25,28,31,34-undecaoxo-3,6,9,12,15,18,21,24,27,30,33-undecaazanonatriacontan-1-oic acid
ID: ALA2298385
PubChem CID: 76327763
Max Phase: Preclinical
Molecular Formula: C71H122N26O13
Molecular Weight: 1547.93
Molecule Type: Protein
Associated Items: